Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 3/2018

Open Access 01-06-2018 | Research Article

Patient and medication factors associated with preventable medication waste and possibilities for redispensing

Authors: C. L. Bekker, B. J. F. van den Bemt, A. C. G. Egberts, M. L. Bouvy, H. Gardarsdottir

Published in: International Journal of Clinical Pharmacy | Issue 3/2018

Login to get access

Abstract

Background Knowledge on factors related to preventable medication waste and waste-reducing interventions, including redispensing unused medications, is needed to maximise effectiveness. Objective To assess patient and medication factors associated with preventable medication waste and possibilities for redispensing unused medications. Setting Dutch community pharmacies. Methods In this cross-sectional study, pharmacy-staff registered patient and medication characteristics of prescription medications returned to 41 Dutch community pharmacies during 1 week in 2014. Medications were classified as preventable waste if the remaining amount could have been prevented and as theoretically eligible for redispensing if the package was unopened, undamaged and ≥ 6 months until the expiry date. Associations were analysed using multivariate logistic regression. Main outcome measures Proportion of medications classified as preventable waste and as eligible for redispensing, including factors associated with these medications. Results Overall, 279 persons returned 759 (low-cost) medications, and 39.3% was classified as preventable waste. These medications were more frequently used by men than women (OR; 1.7[1.2–2.3]) and by older (> 65 years) than younger patients (OR; 1.4[1.0–2.0]). Medications dispensed for longer periods were more often unnecessary wasted (1–3 months OR; 1.8[1.1–3.0], > 3 months 3.2[1.5–6.9]). Of all returned medications, 19.1% was eligible for redispensing. These medications were more frequently used by men than women (OR; 1.9[1.3–2.9]). Medications chronically used were more frequently eligible for redispensing than acute use (OR; 2.1[1.0–4.3]), and used for longer periods (1–3 months OR; 4.6[2.3–8.9], > 3 months 7.8[3.3–18.5]). Conclusions Over one-third of waste due to medications returned to community pharmacies can be prevented. One-fifth of returned medications can be redispensed, but this seems less interesting from an economic viewpoint.
Appendix
Available only for authorised users
Literature
1.
go back to reference OECD Publishing. Health at a Glance 2015. Paris: OECD indicators; 2015. p. 220. OECD Publishing. Health at a Glance 2015. Paris: OECD indicators; 2015. p. 220.
2.
go back to reference Braund R, Yuen YC, Jung J. Identification and quantification of medication returned to Otago pharmacies. NZFP. 2007;34(4):258–62. Braund R, Yuen YC, Jung J. Identification and quantification of medication returned to Otago pharmacies. NZFP. 2007;34(4):258–62.
3.
go back to reference Braund R, Gn G, Matthews R. Investigating unused medications in New Zealand. Pharm World Sci. 2009;31(6):664–9.CrossRefPubMed Braund R, Gn G, Matthews R. Investigating unused medications in New Zealand. Pharm World Sci. 2009;31(6):664–9.CrossRefPubMed
4.
go back to reference Guirguis K. Medications collected for disposal by outreach pharmacists in Australia. Pharm World Sci. 2010;32(1):52–8.CrossRefPubMed Guirguis K. Medications collected for disposal by outreach pharmacists in Australia. Pharm World Sci. 2010;32(1):52–8.CrossRefPubMed
5.
go back to reference Garey KW, Johle ML, Behrman K, Neuhauser MM. Economic consequences of unused medications in Houston, Texas. Ann Pharmacother. 2004;38(7–8):1165–8.CrossRefPubMed Garey KW, Johle ML, Behrman K, Neuhauser MM. Economic consequences of unused medications in Houston, Texas. Ann Pharmacother. 2004;38(7–8):1165–8.CrossRefPubMed
6.
go back to reference Coma A, Modamio P, Lastra CF, Bouvy ML, Mariño EL. Returned medicines in community pharmacies of Barcelona, Spain. Pharm World Sci. 2008;30(3):272–7.CrossRefPubMed Coma A, Modamio P, Lastra CF, Bouvy ML, Mariño EL. Returned medicines in community pharmacies of Barcelona, Spain. Pharm World Sci. 2008;30(3):272–7.CrossRefPubMed
7.
go back to reference Langley C, Marriott J, Mackridge A, Daniszewski R. An analysis of returned medicines in primary care. Pharm World Sci. 2005;27(4):296–9.CrossRefPubMed Langley C, Marriott J, Mackridge A, Daniszewski R. An analysis of returned medicines in primary care. Pharm World Sci. 2005;27(4):296–9.CrossRefPubMed
8.
go back to reference Law AV, Sakharkar P, Zargarzadeh A, Tai BWB, Hess K, Hata M, et al. Taking stock of medication wastage: unused medications in US households. Res Social Adm Pharm. 2015;11(4):571–8.CrossRefPubMed Law AV, Sakharkar P, Zargarzadeh A, Tai BWB, Hess K, Hata M, et al. Taking stock of medication wastage: unused medications in US households. Res Social Adm Pharm. 2015;11(4):571–8.CrossRefPubMed
9.
go back to reference Mackridge AJ, Marriott JF. Returned medicines: waste or a wasted opportunity? J Public Health. 2007;29(3):258–62.CrossRef Mackridge AJ, Marriott JF. Returned medicines: waste or a wasted opportunity? J Public Health. 2007;29(3):258–62.CrossRef
10.
go back to reference Ekedahl ABE. Reasons why medicines are returned to Swedish pharmacies unused. Pharm World Sci. 2006;28(6):352–8.CrossRefPubMed Ekedahl ABE. Reasons why medicines are returned to Swedish pharmacies unused. Pharm World Sci. 2006;28(6):352–8.CrossRefPubMed
11.
go back to reference Wasserfallen J, Bourgeois R, Büla C, Yersin B, Buclin T. Composition and cost of drugs stored at home by elderly patients. Ann Pharmacother. 2003;37(5):731–7.CrossRefPubMed Wasserfallen J, Bourgeois R, Büla C, Yersin B, Buclin T. Composition and cost of drugs stored at home by elderly patients. Ann Pharmacother. 2003;37(5):731–7.CrossRefPubMed
12.
go back to reference Dias-ferreira C, Valente S, Vaz J. Practices of pharmaceutical waste generation and discarding in households across Portugal. Waste Manag Res. 2016;34(10):1006–13.CrossRefPubMed Dias-ferreira C, Valente S, Vaz J. Practices of pharmaceutical waste generation and discarding in households across Portugal. Waste Manag Res. 2016;34(10):1006–13.CrossRefPubMed
13.
go back to reference Persson M, Sabelström E, Gunnarsson B. Handling of unused prescription drugs—knowledge, behaviour and attitude among Swedish people. Environ Int. 2009;35(5):771–4.CrossRefPubMed Persson M, Sabelström E, Gunnarsson B. Handling of unused prescription drugs—knowledge, behaviour and attitude among Swedish people. Environ Int. 2009;35(5):771–4.CrossRefPubMed
14.
go back to reference Vellinga A, Cormican S, Driscoll J, Furey M, Sullivan MO, Cormican M. Public practice regarding disposal of unused medicines in Ireland. Sci Total Environ. 2014;478:98–102.CrossRefPubMed Vellinga A, Cormican S, Driscoll J, Furey M, Sullivan MO, Cormican M. Public practice regarding disposal of unused medicines in Ireland. Sci Total Environ. 2014;478:98–102.CrossRefPubMed
15.
go back to reference Vogler S, Leopold C, Zuidberg C, Habl C. Medicines discarded in household garbage: analysis of a pharmaceutical waste sample in Vienna. J Pharm Policy Pract. 2014;7(1):1–8.CrossRef Vogler S, Leopold C, Zuidberg C, Habl C. Medicines discarded in household garbage: analysis of a pharmaceutical waste sample in Vienna. J Pharm Policy Pract. 2014;7(1):1–8.CrossRef
16.
go back to reference West LM, Diack L, Cordina M, Stewart D. A systematic review of the literature on “medication wastage”: an exploration of causative factors and effect of interventions. Int J Clin Pharm. 2014;36(5):873–81.CrossRefPubMed West LM, Diack L, Cordina M, Stewart D. A systematic review of the literature on “medication wastage”: an exploration of causative factors and effect of interventions. Int J Clin Pharm. 2014;36(5):873–81.CrossRefPubMed
17.
go back to reference Bekker CL, Gardarsdottir H, Egberts TCG, Bouvy ML, van den Bemt BJF. Redispensing of medicines unused by patients: a qualitative study among stakeholders. Int J Clin Pharm. 2017;39(1):196–204.CrossRefPubMed Bekker CL, Gardarsdottir H, Egberts TCG, Bouvy ML, van den Bemt BJF. Redispensing of medicines unused by patients: a qualitative study among stakeholders. Int J Clin Pharm. 2017;39(1):196–204.CrossRefPubMed
18.
go back to reference Lenzer J. US could recycle 10 million unused prescription drugs a year, report says. BMJ. 2014;349:g7677.CrossRefPubMed Lenzer J. US could recycle 10 million unused prescription drugs a year, report says. BMJ. 2014;349:g7677.CrossRefPubMed
19.
go back to reference Tchen J, Vaillancourt R, Pouliot A. Wasted medications, wasted resource. Can Pharm J. 2013;146(4):181–2.CrossRef Tchen J, Vaillancourt R, Pouliot A. Wasted medications, wasted resource. Can Pharm J. 2013;146(4):181–2.CrossRef
21.
go back to reference Mcrae D, Allman M, James D. The redistribution of medicines: could it become a reality? Int J Pharm Pract. 2016;24(6):411–8.CrossRefPubMed Mcrae D, Allman M, James D. The redistribution of medicines: could it become a reality? Int J Pharm Pract. 2016;24(6):411–8.CrossRefPubMed
22.
go back to reference Koster ES, Blom L, Philbert D, Rump W, Bouvy ML. The Utrecht pharmacy practice network for education and research: a network of community and hospital pharmacies in the Netherlands. Int J Clin Pharm. 2014;36(4):669–74.CrossRefPubMed Koster ES, Blom L, Philbert D, Rump W, Bouvy ML. The Utrecht pharmacy practice network for education and research: a network of community and hospital pharmacies in the Netherlands. Int J Clin Pharm. 2014;36(4):669–74.CrossRefPubMed
23.
go back to reference WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2013. Oslo; 2012. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2013. Oslo; 2012.
25.
go back to reference Loikas D, Wettermark B, Von Euler M, Bergman U, Schenck-gustafsson K. Differences in drug utilisation between men and women: a cross-sectional analysis of all dispensed drugs in Sweden. BMJ Open. 2013;3:e002378.CrossRefPubMedPubMedCentral Loikas D, Wettermark B, Von Euler M, Bergman U, Schenck-gustafsson K. Differences in drug utilisation between men and women: a cross-sectional analysis of all dispensed drugs in Sweden. BMJ Open. 2013;3:e002378.CrossRefPubMedPubMedCentral
27.
go back to reference Maeng DD, Ann L, Wright EA. Patient characteristics and healthcare utilization patterns associated with unused medications among medicare patients. Res Soc Adm Pharm. 2017;13(6):1090–4.CrossRef Maeng DD, Ann L, Wright EA. Patient characteristics and healthcare utilization patterns associated with unused medications among medicare patients. Res Soc Adm Pharm. 2017;13(6):1090–4.CrossRef
28.
go back to reference Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5(4):345–51.CrossRefPubMed Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5(4):345–51.CrossRefPubMed
29.
go back to reference Al-Siyabi K, Al-Riyami K. Value and types of medicines returned by patients to sultan qaboos university hospital pharmacy, Oman. Sultan Qaboos Univ Med J. 2007;7(2):109–15.PubMedPubMedCentral Al-Siyabi K, Al-Riyami K. Value and types of medicines returned by patients to sultan qaboos university hospital pharmacy, Oman. Sultan Qaboos Univ Med J. 2007;7(2):109–15.PubMedPubMedCentral
30.
go back to reference Toh MR, Chew L. Turning waste medicines to cost savings: a pilot study on the feasibility of medication recycling as a solution to drug wastage. Palliat Med. 2017;31(1):35–41.CrossRefPubMed Toh MR, Chew L. Turning waste medicines to cost savings: a pilot study on the feasibility of medication recycling as a solution to drug wastage. Palliat Med. 2017;31(1):35–41.CrossRefPubMed
31.
go back to reference VWS. Report hotline Wastage in healthcare-I [Dutch]. Ministry of Health, Welfare and Sport; 2013. VWS. Report hotline Wastage in healthcare-I [Dutch]. Ministry of Health, Welfare and Sport; 2013.
32.
go back to reference Millar J, McNamee P, Heaney D, Selvaraj S, Bond C, Lindsay S, et al. Does a system of instalment dispensing for newly prescribed medicines save NHS costs? Results from a feasibility study. Fam Pract. 2009;26(2):163–8.CrossRefPubMed Millar J, McNamee P, Heaney D, Selvaraj S, Bond C, Lindsay S, et al. Does a system of instalment dispensing for newly prescribed medicines save NHS costs? Results from a feasibility study. Fam Pract. 2009;26(2):163–8.CrossRefPubMed
33.
go back to reference White KG. UK interventions to control medicines wastage: a critical review. Int J Pharm Pract. 2010;18(3):131–40.PubMed White KG. UK interventions to control medicines wastage: a critical review. Int J Pharm Pract. 2010;18(3):131–40.PubMed
34.
go back to reference Vlieland ND, Gardarsdottir H, Bouvy ML, Egberts TCG, Van Den Bemt BJF. The majority of patients do not store their biologic disease-modifying antirheumatic drugs within the recommended temperature range. Rheumatology. 2016;55(4):704–9.CrossRefPubMed Vlieland ND, Gardarsdottir H, Bouvy ML, Egberts TCG, Van Den Bemt BJF. The majority of patients do not store their biologic disease-modifying antirheumatic drugs within the recommended temperature range. Rheumatology. 2016;55(4):704–9.CrossRefPubMed
Metadata
Title
Patient and medication factors associated with preventable medication waste and possibilities for redispensing
Authors
C. L. Bekker
B. J. F. van den Bemt
A. C. G. Egberts
M. L. Bouvy
H. Gardarsdottir
Publication date
01-06-2018
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 3/2018
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-018-0642-8

Other articles of this Issue 3/2018

International Journal of Clinical Pharmacy 3/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.